Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Review · July 10, 2015

Potential Mechanisms of Ketoacidosis Associated With Use of SGLT2 Inhibitors

The Journal of Clinical Endocrinology and Metabolism

 

Additional Info

The Journal of Clinical Endocrinology and Metabolism
Perspective: SGLT2 Inhibitors May Predispose to Ketoacidosis
J. Clin. Endocrinol. Metab. 2015 Jun 18;[EPub Ahead of Print], SI Taylor, JE Blau, KI Rother

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading